Literature DB >> 16226848

12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors.

Timothy Korytko1, Tomas Radivoyevitch, Valdir Colussi, Barry W Wessels, Kunjan Pillai, Robert J Maciunas, Douglas B Einstein.   

Abstract

PURPOSE: To determine whether the 12-Gy radiosurgical volume (12-GyV) correlates with the development of postradiosurgical imaging changes suggestive of radiation necrosis in patients treated for non-arteriovenous malformation (non-AVM) intracranial tumors with gamma knife stereotactic radiosurgery (GKSRS). METHODS AND MATERIALS: A retrospective single-institution review of 129 patients with 198 separate non-AVM tumors was performed. Patients were followed with magnetic resonance imaging (MRI) and physical examinations at 3- to 6-month intervals. Patients who developed postradiosurgical MRI changes suggestive of radiation necrosis were labeled as having either symptomatic radiation necrosis (S-NEC) if they experienced any decline in neurologic examination associated with the imaging changes, or asymptomatic radiation necrosis (A-NEC) if they had a stable or improving neurologic examination.
RESULTS: 12-GyV correlated with risk of S-NEC, which was 23% (for 12-GyV of 0-5 cc), 20% (5-10 cc), 54% (10-15 cc), and 57% (>15 cc). The risk of A-NEC did not significantly change with 12-GyV. Logistic regression analyses showed that the following factors were associated with the development of S-NEC: 12-GyV (p<0.01), occipital and temporal lesions (p<0.01), previous whole-brain radiotherapy (p=0.03), and male sex (p=0.03). Radiosurgical plan conformality did not correlate with the development of S-NEC.
CONCLUSION: The risk of S-NEC, but not A-NEC after GKSRS for non-AVM tumors correlates with 12-GyV, and increases significantly for 12-GyV>0 cc.

Entities:  

Mesh:

Year:  2005        PMID: 16226848     DOI: 10.1016/j.ijrobp.2005.07.980

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  88 in total

1.  Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.

Authors:  Kazuhiro Ohtakara; Shinya Hayashi; Noriyuki Nakayama; Naoyuki Ohe; Hirohito Yano; Toru Iwama; Hiroaki Hoshi
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

2.  Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study.

Authors:  R Wiggenraad; A Verbeek-de Kanter; M Mast; R Molenaar; H B Kal; G Lycklama à Nijeholt; C Vecht; H Struikmans
Journal:  Strahlenther Onkol       Date:  2012-06-23       Impact factor: 3.621

3.  Current status of cranial stereotactic radiosurgery in the UK.

Authors:  Alexis Dimitriadis; Karen J Kirkby; Andrew Nisbet; Catharine H Clark
Journal:  Br J Radiol       Date:  2015-12-21       Impact factor: 3.039

4.  Effective method to reduce the normal brain dose in single-isocenter hypofractionated stereotactic radiotherapy for multiple brain metastases.

Authors:  Jialu Lai; Jia Liu; Jianling Zhao; An Li; Shoupeng Liu; Zhonghua Deng; Qiaoyue Tan; Haitao Wang; Yuming Jia; Kaijian Lei; Lin Zhou
Journal:  Strahlenther Onkol       Date:  2021-03-16       Impact factor: 3.621

Review 5.  Radiation dose-volume effects in the brain.

Authors:  Yaacov Richard Lawrence; X Allen Li; Issam el Naqa; Carol A Hahn; Lawrence B Marks; Thomas E Merchant; Adam P Dicker
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

6.  Determining normal tissue dose in intracranial stereotactic radiosurgery: A diameter-based predictive nomogram.

Authors:  Donal Cummins; Siobhra O'Sullivan; Mary Dunne; Ronan McDermott; Maeve Keys; David Fitzpatrick; Clare Faul; Mohsen Javadpour; Christina Skourou
Journal:  J Radiosurg SBRT       Date:  2020

7.  Two-staged stereotactic radiosurgery for the treatment of large brain metastases: Single institution experience and review of literature.

Authors:  Elizabeth E Ginalis; Taoran Cui; Joseph Weiner; Ke Nie; Shabbar Danish
Journal:  J Radiosurg SBRT       Date:  2020

8.  Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma.

Authors:  E Liniker; A M Menzies; B Y Kong; A Cooper; S Ramanujam; S Lo; R F Kefford; G B Fogarty; A Guminski; T W Wang; M S Carlino; A Hong; G V Long
Journal:  Oncoimmunology       Date:  2016-08-19       Impact factor: 8.110

9.  Clinical Evaluation of Shot-Within-Shot Optimization for Gamma Knife Radiosurgery Planning and Delivery.

Authors:  Perry B Johnson; Maria I Monterroso; Fei Yang; Elizabeth Bossart; Amir Keyvanloo; Eric A Mellon
Journal:  World Neurosurg       Date:  2018-11-24       Impact factor: 2.104

10.  Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease.

Authors:  Stefano Telera; Alessandra Fabi; Andrea Pace; Antonello Vidiri; Vincenzo Anelli; Carmine Maria Carapella; Laura Marucci; Francesco Crispo; Isabella Sperduti; Alfredo Pompili
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.